Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-894-2 | CAS number: 111-67-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
PBT assessment
Administrative data
PBT assessment: overall result
- PBT status:
- the substance is not PBT / vPvB
- Justification:
Ready biodegradability tests were conducted on two analogue substances. Although one analogue substance did not exhibit ready biodegradability in a CO2 evolution test, a degradation rate of >41% and <42% in 28 days was observed; in accordance with ECHA guidance, the observed degradation rate is evidence of inherent, primary degradability (i.e., degradation of 20% or more in a biodegradability assay) and significant mineralisation (>40% degradation in a ready biodegradability test). A second analogue substance exhibited ready biodegradability in a manometric respirometry test, with an observed degradation rate of >80.8 and <80.9% in 28 days. Additionally, a validated QSAR model (EPI Suite BIOWIN 4.10) predicted that the substance is readily biodegradable, based on two modules within the model: BIOWIN 3, which predicted ultimate degradation of the substance in the timeframe of “days-weeks”; and BIOWIN 5, which predicted that the substance “biodegrades fast”. Three additional modules within the model (BIOWIN 1, BIOWIN 2, BIOWIN 5 and BIOWIN 6) predicted that the substance “biodegrades fast”; one module (BIOWIN 4) predicted that primary degradation occurs within the timeframe of “days”. Thus, the inherent biodegradability of the substance is supported by three lines of evidence: an analogue of the substance exhibited inherent, primary degradability and significant mineralisation in a CO2 evolution test; another analogue exhibited ready biodegradability in a manometric respirometry test; and the substance itself is not refractory to ultimate degradation as indicated by QSAR predictions based on its structural components. Therefore, although a definitive determination has not been made, the substance is considered “potentially P” and “not vP”.
Aquatic bioaccumulation testing was not conducted on the substance, and therefore the bioaccumulative properties of the substance cannot be definitively determined. One screening-level datum indicates that the substance may be potential concern for bioaccumulation, i.e., the experimentally-determined octanol-water partition coefficient (log Kow) of 4.51, which is above the screening criterion (log Kow ≤ 4.5) for both “not B” and “not vB”. However, the bioconcentration factor for the substance (BCF = 439.2 L/kg w.w.), as predicted by a validated QSAR model (EPI Suite BCFBAF v3.01), is below the criteria for both bioaccumulative (BCF > 2000 L/kg) and very bioaccumulative (BCF > 5000 L/kg). Therefore, although a definitive determination has not been made, the substance is considered “potentially B” and “potentially vB”, based upon multiple lines of evidence (including laboratory studies and QSAR modeling).
The evaluation of short-term aquatic toxicity tests indicates that the substance does not exhibit aquatic toxicity. The lowest acute L(E)C50 value from tests conducted on an analogue substance was the 48-h EC50 in Daphnia magna, reported as 0.56 mg/L < EC50 < 1 mg/L. These results indicate that the short-term toxicity of the substance is above the screening criteria below which a substance is considered to exhibit potential aquatic toxicity (EC50 or LC50 < 0.1 mg/L) or may be definitively determined to exhibit aquatic toxicity (EC50 or LC50 < 0.01 mg/L). The substance does not exhibit the properties of a carcinogenic, mutagenic or reproductive toxicant (CMR), nor does the substance exhibit specific target organ toxicity in a repeated-dose study (STOT-RE). These results provide a definitive determination that the substance is not toxic with respect to mammalian endpoints.
Therefore, although a complete definitive determination cannot be made with respect to all endpoints, it has been shown by definitive data that the substance is “not T” (based on mammalian toxicity) and by multiple lines of evidence that that the substance is “not vP” and “not T” (based on aquatic toxicity). Based upon screening criteria, the substance is considered “potentially P” and “potentially B/vB”. It is not necessary to have definitive criteria for all five endpoints to make the determinations as to whether the substance is “not PBT” and “not vPvB”. The determination only requires that “each of the three properties persistency, bioaccumulation and toxicity need to be considered in conjunction” (Chapter R.11, “PBT Assessment”, Guidance on information requirements and chemical safety assessment, Version 1.1, ECHA, November 2012, Section R.11.1.2.2, p. 15). In summary, based on data available to date, the substance is “not PBT” (potentially P, potentially B, and not T based on aquatic and mammalian endpoints) and is “not vPvB” (not vP, potentially vB).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.